Premium
Predictors for clinically relevant Gleason score upgrade in patients undergoing radical prostatectomy
Author(s) -
Thomas Christian,
Pfirrmann Karin,
Pieles Frauke,
Bogumil Alexander,
Gillitzer Rolf,
Wiesner Christoph,
Thüroff Joachim W.,
Melchior Sebastian W.
Publication year - 2012
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2011.10187.x
Subject(s) - prostatectomy , medicine , biopsy , cohort , prostate cancer , prostate biopsy , urology , cancer
Study Type – Diagnostic (exploratory cohort) Level of Evidence 2b What’s known on the subject? and What does the study add? Clinically relevant GSU in the prostatectomy specimen is a common phenomenon. Clinically relevant GSU occurs in one of three patients with clinically ‘very’ low‐risk PCa, and a low number of biopsy cores is the key negative predictor. OBJECTIVE • To evaluate clinical predictors for Gleason score upgrade (GSU) in radical prostatectomy (RP) specimen, especially in patients with ‘very’ low risk PCA (T1c and biopsy Gleason score ≤6 and PSA <10 ng/ml and ≤2 positive biopsy cores and PSA density <0.15). Patients and Methods • 402 consecutive patients undergoing RP between 2004 and 2006, including a subgroup of 62 patients with ‘very’ low risk PCA, were examined. • Patients were categorized for clinically relevant GSU (defined as upgrade into a higher PCA risk category). • Parameters including number of biopsy cores obtained, positive biopsy cores, prostate weight, PSA, DRE and pathology department were evaluated for their role as predictors. • Furthermore, GSU in RP specimen was analyzed for its impact on pT‐stage. RESULTS • Clinically relevant GSU occurred in 38.1% in the whole cohort and in 32.3% in the ‘very’ low risk PCA subgroup. Gleason score downgrade (GSD) occurred in 4.7%. • Number of biopsy cores obtained and prostate weight were independent negative predictors of GSU in all 402 patients ( P = 0.02 and P = 0.03, respectively). • In the ‘very’ low risk group, only number of biopsy cores obtained revealed as an independent negative predictor of GSU ( P = 0.02). • PSA, DRE, number of positive cores or pathology department were not associated to GSU. • In the ‘very’ low risk group, GSU was related with extracapsular tumor extension ( P = 0.05). Conclusions • Clinically relevant GSU in RP specimen is still a challenging problem. • Increasing the number of biopsy cores lower this risk significantly. GSD is rare and thus of minor importance for treatment decisions.